Endocrine Society GUIDELINES Bundle (free trial)

Testosterone Therapy in Men with Hypogonadism

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/302958

Contents of this Issue

Navigation

Page 16 of 17

17 Table 8. Monitoring Men Receiving T Therapy Baseline 3–12 months Annually Symptoms ✔ 3–6 months ✔ Adverse events ✔ 3–6 months ✔ Testosterone levels ✔ 3–6 months ✔ Hb/Hct ✔ 3–6 months ✔ PSA/digital rectal examination (DRE) a ✔ 3–12 months ✔ a Prostate monitoring has some potential risks. erefore, the decision to monitor should be a shared decision aer appropriate discussion of risks and benefits.

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Testosterone Therapy in Men with Hypogonadism